Aims & Scope
Cytotherapy, the official journal of the International Society for Cell & Gene Therapy (ISCT®), publishes novel and innovative results from high quality basic, translational and clinical studies in the fields of cell and gene therapy.
Studies evaluating the potency of experimental cell and gene therapies in clinically relevant animal models of disease and describing important advances in cell/gene-based product manufacturing and validation are welcomed.
Results of clinical studies evaluating the safety and efficacy of cell and gene therapies in early and late phase trails are also of interest.
In addition to Short Reports and Full-Length Articles, the journal also accepts Editorials addressing emerging trends and potential controversies in the field, and Review articles summarizing bodies of work that have made lasting impacts in the field.
View Aims & ScopeMetrics & Ranking
Impact Factor
| Year | Value |
|---|---|
| 2025 | 3.2 |
| 2024 | 3.70 |
SJR (SCImago Journal Rank)
| Year | Value |
|---|---|
| 2024 | 1.007 |
Quartile
| Year | Value |
|---|---|
| 2024 | Q1 |
h-index
| Year | Value |
|---|---|
| 2024 | 109 |
Journal Rank
| Year | Value |
|---|---|
| 2024 | 4770 |
Journal Citation Indicator
| Year | Value |
|---|---|
| 2024 | 1300 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Immunology and Microbiology and Medicine, designed to support cutting-edge academic discovery.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
Citation: 13913
Authors: M., K., I., I., F.C, D.S., R.J., A., D.J., E.M.
-
Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement
Citation: 1583
Authors: E.M., K., M., I., I., F.C., R.J., D.S., A.
-
Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT)
Citation: 1573
Authors: Philippe, Bruce A., Louis, Massimo, Adam J., Keith L., Heinz, J. Peter, Kotaro, Jeffrey M.
-
Adipose-derived adult stem cells: isolation, characterization, and differentiation potential
Citation: 871
Authors: J.M., F.
-
Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature
Citation: 635
Authors: S., Y., J., M., K., I., J., D.G., L.
-
Yield of human adipose-derived adult stem cells from liposuction aspirates
Citation: 568
Authors: L., B., S.J., Y.D.C., K., T., A., G.D., J.M.
-
International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials
Citation: 414
Authors: Jacques, Mauro, John, Francesco, Robert J., Joost, Massimo, Willem E., Adrian P., Jeffery M., Peiman, Mickey B.C., Katarina, Ivan, Ian K., Michael, Steve, Luis, Donald G., Valerie, Yufang, David F., Sowmya, Daniel J., Luc
-
Treatment of patients with advanced cancer with the natural killer cell line NK-92
Citation: 401
Authors: Torsten, Dirk, Hans G., Sven, Ruth, Ulrike, Meinolf, Erhard, Oliver G., Gesine